Related Articles
XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells
Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression
TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma
Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
AFAP1‑AS1 induces cisplatin resistance in non‑small cell lung cancer through PI3K/AKT pathway